Most of the ageing-associated pathologies are coupled with a strong inflammatory component that accelerates the progress of the physiopathological functional decline related to ageing. The currently available pharmacological tools for the control of neuroinflammation present several side effects that restrict their application, particularly in chronic disorders. The discovery of the potential anti-inflammatory action exerted by endogenous oestrogens, as well as the finding that activation of oestrogen receptor α results in a significant decrease of inflammation at the cellular level and in models of inflammatory diseases, prompted us to embark in a series of studies aimed at the generation of reporter systems, allowing us to (i) understand the anti-inflammatory action of oestrogens at molecular level; (ii) evaluate the extent to which the action of this steroid hormone was relevant in models of pathologies characterised by a strong inflammatory component; and (iii) investigate the efficacy of novel, synthetic oestrogens endowed with anti-inflammatory activity. Accordingly, we conceived the NFκB-luc2
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reporter mouse, a model characterised by dual reporter genes for fluorescence and bioluminescence imaging under the control of a synthetic DNA able to bind the transcription factor nuclear factor kappa B, the master regulator of the expression of most of the cytokines responsible for the initial phase of acute inflammation. Here, we summarise the philosophy that has driven our research in the past years, as well as some of the results obtained so far.
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| INTRODUCTION
Most pathologies associated with ageing and the ageing process itself are characterised by a strong inflammatory component that accelerates the progress of the physiological or pathology-induced functional decline related to ageing. For example, the chronic inflammatory activation of neuroglia described in numerous neurodegenerative disorders (Parkinson's, Alzheimer's and others) is now considered as a major cause of the precipitous speed of cell death in the final phases of these diseases. 1 Indeed, neurodegeneration would fully involve microglia in clearing the debris associated with neuronal loss and engulfing the misfolded proteins accumulated in the brain parenchyma, therefore distracting them from their regular functions. 2 Thus, the pathology would limit the number of microglia cells involved in patrolling and reparative functions, as well as in the regulation of neural transmission:
this would have severe consequences for brain homeostasis. 3, 4 The same is true for cardiovascular pathologies such as atherosclerosis, where inflammation participates centrally in all stages of this disease, from the initial lesion to the end-stage thrombotic complications. 5 Unfortunately, the pharmacological tools for the control of chronic inflammation available so far are endowed with numerous side effects that limit their application, particularly in chronic disorders. The discovery that endogenous oestrogens have anti-inflammatory potential, as well as the finding that activation of oestrogen receptor (ER)α and ERβ results in a significant decrease of inflammation at the cellular level and in models of inflammatory diseases, 6-14 led us to initiate a series of studies aimed at the generation of model systems, allowing us to (i) understand the anti-inflammatory action of oestrogens at the molecular level; (ii) evaluate the extent to which the action of this steroid hormone was relevant in models of pathologies characterised by a strong inflammatory component; and (iii) study the efficacy of novel, synthetic oestrogens endowed with anti-inflammatory activity.
Here, we summarise the philosophy that has driven our research in the past years, as well as some of the results obtained so far. approximately 600 nm, has been engineered to obtain colours ranging from yellow to red. 16 The availability of fluorescent proteins with discriminable emission wavelengths enabled the generation of multilabelled specimens expressing two or more fluorescent proteins. 
| REPORTER SYSTEMS

| THE GENERATION OF A REPORTER SYSTEM TO STUDY THE EVOLUTION OF THE INFLAMMATORY PROCESS IN LIVING CELLS AND ANIMALS
A brilliant example is provided by the NFκB-luc2-IRES-Egfp reporter system, which we conceived to investigate the dynamics of the action of oestrogen on the inflammatory processes. The system is composed of a dual reporter containing the genes encoding the luciferase and the green fluorescent protein (luc2-IRES-Egfp); both genes had been engineered to obtain enhanced fluorescence and bioluminescence. 21, 22 The two genes were separated by an internal ribosome entry site (IRES), a DNA element encoding a RNA that allows for translation initiation in an end-independent manner, as part of the greater process of protein synthesis. 23 For the promoter, we utilised a DNA sequence able to bind the TF nuclear factor kappa B (NFκB), the master regulator of the expression of most of the cytokines responsible for the initial phase of acute inflammation. [24] [25] [26] Such a promoter was completely synthetic and was the result of a thorough analysis of a panel of genes involved in innate immunity, which led us to identify two major groups of NFκB consensus sequences. These sequences were selected and used for the generation of an array of promoters containing multiple copies of such sequences in different arrangements (Figure 1 ). Studies in both transient and stably transfected cells, using the generated NFκB reporters, enabled us to identify a reporter construct activated by several pro-inflammatory stimuli but not by the anti-inflammatory cytokine interleukin (IL)-4. 27 Using the isolated reporter, we have been able to study, for the first time, the effect of oestrogen administration 
| THE STUDY OF NFκ B ACTIVITY IN WHOLE, LIVING ORGANISMS
The promoter cassette developed was modified further for the generation of the reporter mouse and to enable its integration by homologous recombination into a permissive locus recently described by our group. 28 Considering the large amount of cells ex- expressed the same amount of luciferase was ascribed to differences in the presence of cells for the innate immunity and also differences in the distribution of i.p. injected LPS (eg, brain). Indeed, these results were consistent with subsequent analyses on the expression of the endogenous target genes. 30 To finally demonstrate that oestrogens are able to accelerate the inflammatory response by speeding up the activity of NFκB and rapidly decreasing it, we measured luciferase expression in time in mice treated with LPS alone or LPS + 17β-oestradiol (E 2 ). Accordingly, male NFκB mice of 4 months of age were treated with E 2 (10 μg kg Figure 3 shows that, indeed, the increase in luciferase expression was speeded up in the animals treated with the hormone, with a peak of activity at 3 hours;
at 72 hours, the extent of bioluminescence was lower in these same animals. Thus, even the in vivo analysis of LPS activity indicated that oestrogens can limit (in time) the inflammatory response.
| CONCLUSIONS
The NFκB-luc2 reporter mouse is a novel tool for the study of inflammation and neuroinflammatory processes. The construct generated has been integrated in a known locus allowing for the generalised and NFκB regulated expression of the dual reporter luc2-TdTomato.
Luciferase offers the advantage of whole body imaging or the study of luciferase expression ex vivo in tissue extracts or in brain slices, 31 whereas TdTomato enables the study of NFκB activation at the cellular level in living cells or in tissue slices.
The validity of the system is that the minimal synthetic promoter Thus, this experiment further emphasises the usefulness of a surrogate reporter of TF activity with respect to being less susceptible than complex promoters to unpredictable influences able that enhance/ suppress the activity of the TF on that promoter but not other targets.
The breeding of the NFκB reporter mouse with animal models of neurodegeneration will facilitate the study of the impact of neuroinflammation on the onset and evolution of these pathologies. In addition, the accessibility to this mouse will facilitate the screening and study of novel anti-inflammatory compounds.
Moreover, the use of reporter mice allows all of these goals to be reached with a significant reduction in the number of animals used, as well as their distress, and is in full compliance with the 3R regulations (Reduction, Refinement, Reduction).
